Differential diagnosis of hydroxychloroquine-induced retinal damage
Coronavirus infection is currently en extremely relevant scientific topic due to the emergence of a new serotype that causes a condition identified as Severe Acute Respiratory Syndrome (SARS)-COV-2. Chloroquine and hydroxychloroquine have a long history of use against other infectious diseases, they are available and inexpensive, so the possibility of using them in vivo and in vitro to suppress the infectious agent was examined. Despite the noted therapeutic potential of these drugs, it was necessary to take into account the toxicological aspects that dictate the importance of rational use of 4-aminoquinoline derivatives. This review analyzes literature on the development patterns of hydroxychloroquine retinopathy, basic principles of diagnosis and differentiation of this condition from other types of retinal pathology.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:136 |
|---|---|
| Enthalten in: |
Vestnik oftalmologii - 136(2020), 4. Vyp. 2 vom: 03., Seite 265-271 |
| Sprache: |
Russisch |
|---|
| Weiterer Titel: |
Differentsial'naya diagnostika porazheniya setchatki pri toksicheskom vozdeistvii gidroksikhlorokhina |
|---|
| Beteiligte Personen: |
Budzinskaya, M V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 04.09.2020 Date Revised 04.09.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17116/oftalma2020136042265 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314530800 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314530800 | ||
| 003 | DE-627 | ||
| 005 | 20231225152929.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.17116/oftalma2020136042265 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1048.xml |
| 035 | |a (DE-627)NLM314530800 | ||
| 035 | |a (NLM)32880149 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Budzinskaya, M V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Differential diagnosis of hydroxychloroquine-induced retinal damage |
| 246 | 3 | 3 | |a Differentsial'naya diagnostika porazheniya setchatki pri toksicheskom vozdeistvii gidroksikhlorokhina |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.09.2020 | ||
| 500 | |a Date Revised 04.09.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Coronavirus infection is currently en extremely relevant scientific topic due to the emergence of a new serotype that causes a condition identified as Severe Acute Respiratory Syndrome (SARS)-COV-2. Chloroquine and hydroxychloroquine have a long history of use against other infectious diseases, they are available and inexpensive, so the possibility of using them in vivo and in vitro to suppress the infectious agent was examined. Despite the noted therapeutic potential of these drugs, it was necessary to take into account the toxicological aspects that dictate the importance of rational use of 4-aminoquinoline derivatives. This review analyzes literature on the development patterns of hydroxychloroquine retinopathy, basic principles of diagnosis and differentiation of this condition from other types of retinal pathology | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a toxic retinopathy | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Durzhinskaya, M H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vestnik oftalmologii |d 1945 |g 136(2020), 4. Vyp. 2 vom: 03., Seite 265-271 |w (DE-627)NLM000172073 |x 0042-465X |7 nnns |
| 773 | 1 | 8 | |g volume:136 |g year:2020 |g number:4. Vyp. 2 |g day:03 |g pages:265-271 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17116/oftalma2020136042265 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 136 |j 2020 |e 4. Vyp. 2 |b 03 |h 265-271 | ||